ASNRT — Arab Society of Nephrology and Renal Transplantation

النسخة العربية من هذه الصفحة

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE)

Starting the kidney-protective drugs finerenone and empagliflozin together lowered urine protein more than starting either one alone in people with diabetic kidney disease, and was well tolerated.

Category

Research

Source

The New England Journal of Medicine

Read the full abstract on PubMed

More from ASNRT News

Browse the latest news, society announcements, KDIGO guideline updates, and AJNT issue releases on the ASNRT newsroom.

All news · ASNRT home